DA
Therapeutic Areas
MiRXES Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GASTROClear | Gastric cancer early detection | Commercial |
| LUNGClear | Lung cancer early detection | Commercial |
| APEX Tissue | Targeted oncology panel (58 genes) | Commercial |
| COMPASS Tissue | Comprehensive oncology panel (1021 genes) | Commercial |
| Fortitude Kit 2.1 | SARS‑CoV‑2 & Influenza A/B detection | Commercial |
| Multi‑Cancer Screening Test (MCST) | Pan‑cancer early detection | Phase 2 |